Ipsen is a global biopharmaceutical group dedicated to improving lives and health outcomes through innovative medicines in Oncology, Neuroscience and Rare Disease. We also have a well-established and successful Consumer Healthcare business. We are committed to discovering new treatments in areas with high unmet medical needs and improving the quality of life for patients.
We have 90 years of heritage as a family-owned company and a publicity traded business
We sell more than 20 drugs in 115 countries and have a direct commercial presence in over 30 countries worldwide
We focus on Speciality Care with businesses in Oncology, Neuroscience and Rare Disease, as well as a Consumer Healthcare business
We have over 5,700 employees worldwide, who are based at our many sites, including 8 R&D sites and industrial sites.
We are proud that 15,6% of our sales reinvested in R&D
Showing 1 to 1 of 1 (1 Pages)